Open
SectorHealthcare
27.83 2.24
24h
Min
27.03
Max
27.74
Income | -18M -151M |
---|---|
Sales | -26M 139M |
Profit margin | -108.463 |
Employees | 1,294 |
EBITDA | -18M -126M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +191.94% upside |
Next Earnings | 4 lis 2025 |
---|
Market Cap | -935M 2.7B |
---|---|
Previous open | 25.59 |
Previous close | 27.83 |
By Acuity
91%
9%
360 / 374 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 80.4 USD 191.94%
High 128 USD
Low 29 USD
Based on 17 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$